ATTUNE Revision System in the Revision Total Knee Arthroplasty Population

NCT ID: NCT03153475

Last Updated: 2025-11-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-30

Study Completion Date

2029-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Five-year, Prospective, multi-center, non-randomized, non-controlled study of the ATTUNE® Revision total knee prostheses, utilizing the fixed bearing (FB) and rotating platform (RP) tibial component with the posterior stabilizing (PS) femoral component in revision total knee arthroplasty.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is designed as a non-comparative, worldwide, multi-center study with up to 30 sites that will intend to implant a total of 400 Subjects (200 PS RP and 200 PS FB) with the study devices. The follow-up period of 5 years was selected to cover both the early post-operative period as well as the medium term period which is a good indicator of longer term survivorship.

The primary endpoint of survivorship at 5 years was selected to capture the time period during which the majority of revision failures occur while providing a good indication of long term survivorship. The secondary outcomes include commonly used measures of clinical performance that will allow for comparison with published literature. Additionally, patient reported outcomes, AORI bone defect classification , satisfaction and pain scores will be collected and analyzed.

Male and female Subjects, age 22-80 years, inclusive, with a failed primary knee arthroplasty, including unicompartmental or failed previous revision TKA, who are suitable candidates for revision TKA using the ATTUNE® Revision system are eligible for enrollment in this study. The use of the ATTUNE Revision system includes both partial and complete revision surgical procedures, including implantation of revision components as the second stage within a two-stage treatment for infection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Revision Total Knee Arthroplasty

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Revision knee surgery, implant replacement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ATTUNE Revision Knee System

The ATTUNE Revision system is complementary to the ATTUNE primary knee portfolio and includes both rotating platform (RP) and fixed bearing (FB) configurations. The system includes a full compliment of implants designed to address the challenges faced in revision knee surgeries. These implants include Stemmable tibial and femoral components, augments, sleeves and offsets

Group Type OTHER

ATTUNE Revision Knee System in Revision Total Knee Arthroplasty

Intervention Type DEVICE

Implants from the ATTUNE Revision Knee System will be used to treat subjects whose surgeons have determined their existing implants need to be removed and replaced.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ATTUNE Revision Knee System in Revision Total Knee Arthroplasty

Implants from the ATTUNE Revision Knee System will be used to treat subjects whose surgeons have determined their existing implants need to be removed and replaced.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

previous unsuccessful knee replacement, knee revision

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subject is male or female and between the ages of 22 and 80 years at the time of consent, inclusive.
2. Subject presents with a primary knee arthroplasty (primary TKA, unicompartmental) or prior revision TKA that requires a revision procedure of implanted tibial and/or femoral components.
3. The decision to perform a knee revision with the study device is regardless of the research.
4. Subject that is willing to give voluntary, written informed consent to participate in this clinical investigation and authorize the transfer of his/her information to the Sponsor
5. Subject is currently not bedridden
6. The devices are to be used according to the approved indications.Subject is able to read, and comprehend the Informed Consent Document as well as complete the required PROMs in either English or one of the available translations.

Exclusion Criteria

1. The Subject is a woman who is pregnant or lactating.
2. Contralateral knee has already been enrolled in this study.
3. Subject had a contralateral amputation.
4. Subject is currently diagnosed with radicular pain from the spine that radiates into the limb to receive RTKA.
5. Subject has participated in a clinical investigation with an investigational product (drug or device) in the last three (3) months.
6. Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims.
7. Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in the last 5 years) or has a psychological disorder that could affect his/her ability to complete patient reported questionnaires or be compliant with follow-up requirements.
8. Subject was diagnosed and is taking prescription medications to treat a muscular disorder that limits mobility due to severe stiffness and pain such as fibromyalgia or polymyalgia.
9. Subject has a significant neurological or musculoskeletal disorder(s) or disease that may adversely affect gait or weight bearing activities (e.g., muscular dystrophy, multiple sclerosis, Charcot disease).
10. Subject has a medical condition with less than five (5) years life expectancy as determined by the Investigator.
11. Uncontrolled gout
Minimum Eligible Age

22 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

DePuy Orthopaedics

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sukhjeet Kaur

Role: STUDY_DIRECTOR

Sponsor GmbH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Scripps Clinic Torrey Pines

San Diego, California, United States

Site Status

Colorado Joint Replacement

Denver, Colorado, United States

Site Status

Orthopaedic Center of the Rockies

Fort Collins, Colorado, United States

Site Status

Orthopedic Partners

Niantic, Connecticut, United States

Site Status

Florida Orthopedic Associates

DeLand, Florida, United States

Site Status

Arthroplasty Foundation

Louisville, Kentucky, United States

Site Status

University of Mississippi Medical Center

Jackson, Mississippi, United States

Site Status

Mery Hospital

Ozark, Missouri, United States

Site Status

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States

Site Status

Rothman Institute

Egg Harbor, New Jersey, United States

Site Status

UNC Orthopaedics

Chapel Hill, North Carolina, United States

Site Status

OrthoCarolina Hip and Knee Center

Charlotte, North Carolina, United States

Site Status

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States

Site Status

Southern Joint Replacement Institute

Nashville, Tennessee, United States

Site Status

Texas Institute for Hip & Knee Surgery

Austin, Texas, United States

Site Status

Fondren Orthopedic Group

Houston, Texas, United States

Site Status

The Gold Coast Centre for Bone and Joint Surgery

Gold Coast, , Australia

Site Status

St. John of God Murdoch Hospital

Perth, , Australia

Site Status

Krankenhaus der Barmherzigen Schwestern Linz Betriebsgesellschaft m.b.H.

Linz, , Austria

Site Status

MoRe Foundation

Antwerp, , Belgium

Site Status

London Health Sciences Centre University Hospital

London, Ontario, Canada

Site Status

Concordia Joint Replacement

Winnipeg, , Canada

Site Status

CHRU La Cavale Blanche

Brest, , France

Site Status

Centre Hospitalier Universitaire de Rennes

Rennes, , France

Site Status

Klinik und Poliklinik für Orthopädie und Sportorthopädie am Klinikum rechts der Isar der Technischen Universität Münche

Munich, , Germany

Site Status

Asklepios Orthopädische Klinik Lindenlohe

Schwandorf in Bayern, , Germany

Site Status

South Infirmary Public Hospital

Cork, , Ireland

Site Status

CLINICHE GAVAZZENI SPA aka Humanitas Castelli

Bergamo, , Italy

Site Status

University Hospital Maastricht

Maastricht, , Netherlands

Site Status

Wellington Hospital

Wellington, , New Zealand

Site Status

Kantonsspital Baselland (Bruderholz, Liestal, Laufen), Department of Orthopaedic Surgery and Traumatology

Basel, , Switzerland

Site Status

Hampshire Hospitals NHS Foundation Trust

Basingstoke, , United Kingdom

Site Status

Victoria Hospital NHS Fife

Kirkcaldy, , United Kingdom

Site Status

Chapel Allerton Orthopaedic Centre

Leeds, , United Kingdom

Site Status

James Cook University Hospital

North Yorks, , United Kingdom

Site Status

The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust

Oswestry, , United Kingdom

Site Status

Nuffield Orthopaedic Centre

Oxford, , United Kingdom

Site Status

Wrightington Hospital

Wigan, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Belgium Canada France Germany Ireland Italy Netherlands New Zealand Switzerland United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DSJ-2016-02

Identifier Type: -

Identifier Source: org_study_id